Merck KGaA (XSWX:MER) Accumulated Depreciation: CHF0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:MER Merck KGaA XSWX:MER
84 GF Score
Price CHF133.05
GF Value CHF129.34
! 9 Warning Signs
View Full Analysis

What is Merck KGaA Accumulated Depreciation?

Merck KGaA XSWX:MER 84 Accumulated Depreciation is CHF0 Mil as of Mar. 2026. GuruFocus rates XSWX:MER with a GF Score™ of 84/100 and a GF Value™ of CHF129.34. The stock has 9 warning signs investors should review.

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Merck KGaA's quarterly accumulated depreciation increased from Sep. 2025 (CHF0 Mil) to Dec. 2025 (CHF-8,956 Mil) but then stayed the same from Dec. 2025 (CHF-8,956 Mil) to Mar. 2026 (CHF0 Mil).

Merck KGaA's annual accumulated depreciation increased from Dec. 2023 (CHF-8,381 Mil) to Dec. 2024 (CHF-8,484 Mil) and increased from Dec. 2024 (CHF-8,484 Mil) to Dec. 2025 (CHF-8,956 Mil).

Merck KGaA Accumulated Depreciation Related Terms

Merck KGaA Accumulated Depreciation Historical Data

* Premium members only.

The historical data trend for Merck KGaA's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Merck KGaA Accumulated Depreciation Chart

Merck KGaA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accumulated Depreciation
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7,901.87 -8,198.87 -8,381.11 -8,483.74 -8,956.26

Merck KGaA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accumulated Depreciation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -8,956.26 0.00
XSWX:MER
84GF Score
Merck KGaA XSWX:MER
Accumulated Depreciation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Merck KGaA Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

What does a Accumulated Depreciation of CHF0 Mil mean?
Merck KGaA (XSWX:MER) has a Accumulated Depreciation of CHF0 Mil as of Mar. 2026. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Merck KGaA and its competitors.
Is Merck KGaA's Accumulated Depreciation too high?
Merck KGaA's current Accumulated Depreciation is CHF0 Mil. Overall, Merck KGaA has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does Merck KGaA's Accumulated Depreciation compare to ZTS and UTHR?
Merck KGaA's Accumulated Depreciation of CHF0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accumulated Depreciation for a Drug Manufacturers company?
A good Accumulated Depreciation depends on the Drug Manufacturers industry context. However, Accumulated Depreciation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accumulated Depreciation mean?
A high Accumulated Depreciation can signal that a stock is expensive relative to its fundamentals. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Merck KGaA and its competitors. Merck KGaA's current Accumulated Depreciation is CHF0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Merck KGaA stock overvalued right now?
Merck KGaA (XSWX:MER) has a current Accumulated Depreciation of CHF0 Mil. The stock's GF Value™ is CHF129.34, compared to a current price of CHF133.05 — trading 2.9% above its estimated fair value. The current Accumulated Depreciation is CHF0 Mil. Merck KGaA's overall GF Score™ is 84/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accumulated Depreciation calculated?
Accumulated Depreciation is calculated from a company's financial statements. For Merck KGaA (XSWX:MER), the current Accumulated Depreciation is CHF0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Merck KGaA (XSWX:MER) Overvalued in 2026?

Based on GuruFocus' analysis, Merck KGaA stock appears to be overvalued. The current stock price of CHF133.05 is trading 2.9% above its estimated GF Value™ of CHF129.34.

Key valuation signals for XSWX:MER:

  • Accumulated Depreciation: CHF0 Mil
  • GF Value™: CHF129.34 vs. price of CHF133.05 (2.9% above fair value)
  • GF Score™: 84/100 with 9 warning signs

No single metric tells the full story. See the XSWX:MER stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Merck KGaA Business Description

Address Frankfurter Strasse 250, Darmstadt, HE, DEU, 64293
Merck KGaA operates in three main segments: Life Science, Electronics, and Healthcare. The Life Science segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. The Electronics segment offers specialty materials to manufacture a variety of products, such as semiconductors and flat-screen televisions. In the healthcare segment, Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.
84GF Score

Get the complete analysis for XSWX:MER

Accumulated Depreciation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF133.05
Price
CHF129.34
GF Value